ANGELA COMBS: Open Payments
NPI 1093119232 · RICHLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 18 payments from 6 companies in 2025. Trend: 2023 $36,306 · 2024 $7,421 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $274 |
| E.R. Squibb & Sons, L.L.C. | 2 | $251 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $174 |
| Janssen Pharmaceuticals, Inc | 2 | $148 |
| Alkermes, Inc. | 1 | $119 |
| Neurocrine BioSciences, Inc. | 4 | $92 |
Products named: Auvelity, COBENFY, CAPLYTA, INVEGA SUSTENNA, ARISTADA, INGREZZA.
Industry payments across WA — which companies pay providers there.
